CA2608643A1 - Gene-based algorithmic cancer prognosis - Google Patents
Gene-based algorithmic cancer prognosis Download PDFInfo
- Publication number
- CA2608643A1 CA2608643A1 CA002608643A CA2608643A CA2608643A1 CA 2608643 A1 CA2608643 A1 CA 2608643A1 CA 002608643 A CA002608643 A CA 002608643A CA 2608643 A CA2608643 A CA 2608643A CA 2608643 A1 CA2608643 A1 CA 2608643A1
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- gene
- genes
- tumor sample
- grade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 130
- 108090000623 proteins and genes Proteins 0.000 title claims description 185
- 201000011510 cancer Diseases 0.000 title claims description 35
- 238000004393 prognosis Methods 0.000 title abstract description 15
- 230000014509 gene expression Effects 0.000 claims abstract description 102
- 238000000034 method Methods 0.000 claims abstract description 56
- 239000000523 sample Substances 0.000 claims description 90
- 206010006187 Breast cancer Diseases 0.000 claims description 84
- 208000026310 Breast neoplasm Diseases 0.000 claims description 81
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims description 66
- 108010038795 estrogen receptors Proteins 0.000 claims description 61
- 229960001603 tamoxifen Drugs 0.000 claims description 33
- 238000011282 treatment Methods 0.000 claims description 26
- 238000004458 analytical method Methods 0.000 claims description 18
- 108090000468 progesterone receptors Proteins 0.000 claims description 17
- 102000003998 progesterone receptors Human genes 0.000 claims description 16
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 208000014018 liver neoplasm Diseases 0.000 claims description 12
- 238000002512 chemotherapy Methods 0.000 claims description 11
- 239000003886 aromatase inhibitor Substances 0.000 claims description 10
- 238000011269 treatment regimen Methods 0.000 claims description 9
- 230000035755 proliferation Effects 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 201000009030 Carcinoma Diseases 0.000 claims description 7
- 229940046844 aromatase inhibitors Drugs 0.000 claims description 7
- 108020004999 messenger RNA Proteins 0.000 claims description 7
- 206010005003 Bladder cancer Diseases 0.000 claims description 6
- 208000003174 Brain Neoplasms Diseases 0.000 claims description 6
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 6
- 206010009944 Colon cancer Diseases 0.000 claims description 6
- 102100025191 Cyclin-A2 Human genes 0.000 claims description 6
- 101000934320 Homo sapiens Cyclin-A2 Proteins 0.000 claims description 6
- 102100035692 Importin subunit alpha-1 Human genes 0.000 claims description 6
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 6
- 206010033128 Ovarian cancer Diseases 0.000 claims description 6
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 6
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 6
- 206010060862 Prostate cancer Diseases 0.000 claims description 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 6
- 206010038389 Renal cancer Diseases 0.000 claims description 6
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 6
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 6
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 6
- 208000006593 Urologic Neoplasms Diseases 0.000 claims description 6
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 6
- 201000010881 cervical cancer Diseases 0.000 claims description 6
- 208000029742 colonic neoplasm Diseases 0.000 claims description 6
- 206010017758 gastric cancer Diseases 0.000 claims description 6
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 6
- 201000010982 kidney cancer Diseases 0.000 claims description 6
- 201000007270 liver cancer Diseases 0.000 claims description 6
- 201000005202 lung cancer Diseases 0.000 claims description 6
- 208000020816 lung neoplasm Diseases 0.000 claims description 6
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 6
- 201000001441 melanoma Diseases 0.000 claims description 6
- 201000002528 pancreatic cancer Diseases 0.000 claims description 6
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 6
- 201000011549 stomach cancer Diseases 0.000 claims description 6
- 201000002510 thyroid cancer Diseases 0.000 claims description 6
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 6
- 102100032311 Aurora kinase A Human genes 0.000 claims description 5
- 101000798300 Homo sapiens Aurora kinase A Proteins 0.000 claims description 5
- 108010002687 Survivin Proteins 0.000 claims description 5
- 108010011989 karyopherin alpha 2 Proteins 0.000 claims description 5
- 101000830894 Homo sapiens Targeting protein for Xklp2 Proteins 0.000 claims description 4
- 102100024813 Targeting protein for Xklp2 Human genes 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000009261 endocrine therapy Methods 0.000 claims description 4
- 229940122815 Aromatase inhibitor Drugs 0.000 claims description 3
- 102100023374 Forkhead box protein M1 Human genes 0.000 claims description 3
- 101150074790 G3 gene Proteins 0.000 claims description 3
- 101000593405 Homo sapiens Myb-related protein B Proteins 0.000 claims description 3
- 101000807354 Homo sapiens Ubiquitin-conjugating enzyme E2 C Proteins 0.000 claims description 3
- 102100034670 Myb-related protein B Human genes 0.000 claims description 3
- 102100037256 Ubiquitin-conjugating enzyme E2 C Human genes 0.000 claims description 3
- 238000004166 bioassay Methods 0.000 claims description 3
- 229940034984 endocrine therapy antineoplastic and immunomodulating agent Drugs 0.000 claims description 3
- 108010008599 Forkhead Box Protein M1 Proteins 0.000 claims description 2
- 101150080073 G1 gene Proteins 0.000 claims description 2
- 229940124650 anti-cancer therapies Drugs 0.000 claims description 2
- 238000009175 antibody therapy Methods 0.000 claims description 2
- 238000011319 anticancer therapy Methods 0.000 claims description 2
- 230000002124 endocrine Effects 0.000 claims description 2
- 238000012502 risk assessment Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 102100038595 Estrogen receptor Human genes 0.000 claims 4
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 claims 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 1
- 102000000763 Survivin Human genes 0.000 claims 1
- 238000003753 real-time PCR Methods 0.000 claims 1
- 102000015694 estrogen receptors Human genes 0.000 description 58
- 102000004169 proteins and genes Human genes 0.000 description 45
- 230000004083 survival effect Effects 0.000 description 32
- 238000002493 microarray Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 238000013456 study Methods 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 108090000765 processed proteins & peptides Proteins 0.000 description 15
- 230000002950 deficient Effects 0.000 description 13
- 238000010200 validation analysis Methods 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 12
- 206010027476 Metastases Diseases 0.000 description 11
- 239000002671 adjuvant Substances 0.000 description 11
- 230000022131 cell cycle Effects 0.000 description 11
- 238000000491 multivariate analysis Methods 0.000 description 11
- 238000012423 maintenance Methods 0.000 description 10
- 230000009401 metastasis Effects 0.000 description 9
- 238000012549 training Methods 0.000 description 9
- 238000007473 univariate analysis Methods 0.000 description 8
- 108700020796 Oncogene Proteins 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 7
- 210000000349 chromosome Anatomy 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 101150094765 70 gene Proteins 0.000 description 6
- 102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 6
- 102100021389 DNA replication licensing factor MCM4 Human genes 0.000 description 6
- 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 6
- 101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 6
- 101000615280 Homo sapiens DNA replication licensing factor MCM4 Proteins 0.000 description 6
- 102000004243 Tubulin Human genes 0.000 description 6
- 108090000704 Tubulin Proteins 0.000 description 6
- 230000004663 cell proliferation Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000328 estrogen antagonist Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229940046836 anti-estrogen Drugs 0.000 description 5
- 230000001833 anti-estrogenic effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- 108091007065 BIRCs Proteins 0.000 description 4
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 4
- 102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 4
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 102100037114 Elongin-C Human genes 0.000 description 4
- 102100023745 GTP-binding protein 4 Human genes 0.000 description 4
- 102100024501 Histone H3-like centromeric protein A Human genes 0.000 description 4
- 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 4
- 101000575639 Homo sapiens Ribonucleoside-diphosphate reductase subunit M2 Proteins 0.000 description 4
- 101000724404 Homo sapiens Saccharopine dehydrogenase Proteins 0.000 description 4
- 101000838456 Homo sapiens Tubulin alpha-1B chain Proteins 0.000 description 4
- 101000838350 Homo sapiens Tubulin alpha-1C chain Proteins 0.000 description 4
- 102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 4
- 108010062228 Karyopherins Proteins 0.000 description 4
- 102000011781 Karyopherins Human genes 0.000 description 4
- 102100026006 Ribonucleoside-diphosphate reductase subunit M2 Human genes 0.000 description 4
- 102100028294 Saccharopine dehydrogenase Human genes 0.000 description 4
- 102100028969 Tubulin alpha-1B chain Human genes 0.000 description 4
- 102100028985 Tubulin alpha-1C chain Human genes 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000034303 cell budding Effects 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000001325 log-rank test Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000002438 mitochondrial effect Effects 0.000 description 4
- 238000010837 poor prognosis Methods 0.000 description 4
- XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 102100022299 All trans-polyprenyl-diphosphate synthase PDSS1 Human genes 0.000 description 3
- -1 BIRCS Proteins 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 3
- 102100023344 Centromere protein F Human genes 0.000 description 3
- 102000016736 Cyclin Human genes 0.000 description 3
- 108050006400 Cyclin Proteins 0.000 description 3
- 102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 102100026121 Flap endonuclease 1 Human genes 0.000 description 3
- 101000902409 Homo sapiens All trans-polyprenyl-diphosphate synthase PDSS1 Proteins 0.000 description 3
- 101000907941 Homo sapiens Centromere protein F Proteins 0.000 description 3
- 101000881731 Homo sapiens Elongin-C Proteins 0.000 description 3
- 101000828886 Homo sapiens GTP-binding protein 4 Proteins 0.000 description 3
- 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 description 3
- 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 3
- 102100037001 Next to BRCA1 gene 1 protein Human genes 0.000 description 3
- 102000007999 Nuclear Proteins Human genes 0.000 description 3
- 108010089610 Nuclear Proteins Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 3
- 108010081734 Ribonucleoproteins Proteins 0.000 description 3
- 102000004389 Ribonucleoproteins Human genes 0.000 description 3
- 102100020695 Ubiquitin-conjugating enzyme E2 N Human genes 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 230000006369 cell cycle progression Effects 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000009274 differential gene expression Effects 0.000 description 3
- 238000011223 gene expression profiling Methods 0.000 description 3
- 108010003425 hyaluronan-mediated motility receptor Proteins 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- KIAPWMKFHIKQOZ-UHFFFAOYSA-N 2-[[(4-fluorophenyl)-oxomethyl]amino]benzoic acid methyl ester Chemical compound COC(=O)C1=CC=CC=C1NC(=O)C1=CC=C(F)C=C1 KIAPWMKFHIKQOZ-UHFFFAOYSA-N 0.000 description 2
- 102100040961 26S proteasome non-ATPase regulatory subunit 12 Human genes 0.000 description 2
- 102100033811 A-kinase anchor protein 11 Human genes 0.000 description 2
- 102100028175 Abasic site processing protein HMCES Human genes 0.000 description 2
- 102100022117 Abnormal spindle-like microcephaly-associated protein Human genes 0.000 description 2
- 102100032306 Aurora kinase B Human genes 0.000 description 2
- 102100023962 Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 Human genes 0.000 description 2
- 102100024486 Borealin Human genes 0.000 description 2
- 102100021714 Bystin Human genes 0.000 description 2
- 108010008629 CA-125 Antigen Proteins 0.000 description 2
- 102000007269 CA-125 Antigen Human genes 0.000 description 2
- 108700020472 CDC20 Proteins 0.000 description 2
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 2
- 102100024479 Cell division cycle-associated protein 3 Human genes 0.000 description 2
- 108010076303 Centromere Protein A Proteins 0.000 description 2
- 108091060290 Chromatid Proteins 0.000 description 2
- 102100023774 Cold-inducible RNA-binding protein Human genes 0.000 description 2
- 102100026280 Cryptochrome-2 Human genes 0.000 description 2
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 2
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 2
- 102100032522 Cyclin-dependent kinases regulatory subunit 2 Human genes 0.000 description 2
- 102100030270 Cysteine-rich hydrophobic domain-containing protein 1 Human genes 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010075031 Cytochromes c Proteins 0.000 description 2
- 102100037147 Cytoplasmic dynein 2 heavy chain 1 Human genes 0.000 description 2
- 102100035474 DNA polymerase kappa Human genes 0.000 description 2
- 102100034490 DNA repair and recombination protein RAD54B Human genes 0.000 description 2
- 102100039606 DNA replication licensing factor MCM3 Human genes 0.000 description 2
- 102100028473 DNA-directed RNA polymerases I, II, and III subunit RPABC4 Human genes 0.000 description 2
- 101710087821 Deformed epidermal autoregulatory factor 1 Proteins 0.000 description 2
- 102100037980 Disks large-associated protein 5 Human genes 0.000 description 2
- 102100036109 Dual specificity protein kinase TTK Human genes 0.000 description 2
- 102100029075 Exonuclease 1 Human genes 0.000 description 2
- 102100039207 Exportin-T Human genes 0.000 description 2
- 108050002219 Flap endonuclease 1 Proteins 0.000 description 2
- 101001067614 Flaveria pringlei Serine hydroxymethyltransferase 2, mitochondrial Proteins 0.000 description 2
- 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 2
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 2
- 102100033201 G2/mitotic-specific cyclin-B2 Human genes 0.000 description 2
- 102100023919 Histone H2A.Z Human genes 0.000 description 2
- 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 102100022107 Holliday junction recognition protein Human genes 0.000 description 2
- 101000612528 Homo sapiens 26S proteasome non-ATPase regulatory subunit 12 Proteins 0.000 description 2
- 101000779390 Homo sapiens A-kinase anchor protein 11 Proteins 0.000 description 2
- 101001006387 Homo sapiens Abasic site processing protein HMCES Proteins 0.000 description 2
- 101000900939 Homo sapiens Abnormal spindle-like microcephaly-associated protein Proteins 0.000 description 2
- 101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 2
- 101000975541 Homo sapiens Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 Proteins 0.000 description 2
- 101000762405 Homo sapiens Borealin Proteins 0.000 description 2
- 101000896419 Homo sapiens Bystin Proteins 0.000 description 2
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 2
- 101000980907 Homo sapiens Cell division cycle-associated protein 3 Proteins 0.000 description 2
- 101000906744 Homo sapiens Cold-inducible RNA-binding protein Proteins 0.000 description 2
- 101000855613 Homo sapiens Cryptochrome-2 Proteins 0.000 description 2
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 2
- 101000942317 Homo sapiens Cyclin-dependent kinases regulatory subunit 2 Proteins 0.000 description 2
- 101000991108 Homo sapiens Cysteine-rich hydrophobic domain-containing protein 1 Proteins 0.000 description 2
- 101000881344 Homo sapiens Cytoplasmic dynein 2 heavy chain 1 Proteins 0.000 description 2
- 101001094659 Homo sapiens DNA polymerase kappa Proteins 0.000 description 2
- 101000865085 Homo sapiens DNA polymerase theta Proteins 0.000 description 2
- 101001132263 Homo sapiens DNA repair and recombination protein RAD54B Proteins 0.000 description 2
- 101000963174 Homo sapiens DNA replication licensing factor MCM3 Proteins 0.000 description 2
- 101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 2
- 101000723789 Homo sapiens DNA-directed RNA polymerases I, II, and III subunit RPABC4 Proteins 0.000 description 2
- 101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 description 2
- 101000659223 Homo sapiens Dual specificity protein kinase TTK Proteins 0.000 description 2
- 101001011859 Homo sapiens Elongin-A Proteins 0.000 description 2
- 101001011846 Homo sapiens Elongin-B Proteins 0.000 description 2
- 101000918264 Homo sapiens Exonuclease 1 Proteins 0.000 description 2
- 101000745703 Homo sapiens Exportin-T Proteins 0.000 description 2
- 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 2
- 101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 description 2
- 101000713023 Homo sapiens G2/mitotic-specific cyclin-B2 Proteins 0.000 description 2
- 101000905054 Homo sapiens Histone H2A.Z Proteins 0.000 description 2
- 101000981071 Homo sapiens Histone H3-like centromeric protein A Proteins 0.000 description 2
- 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 2
- 101001045907 Homo sapiens Holliday junction recognition protein Proteins 0.000 description 2
- 101001008949 Homo sapiens Kinesin-like protein KIF14 Proteins 0.000 description 2
- 101001112162 Homo sapiens Kinetochore protein NDC80 homolog Proteins 0.000 description 2
- 101001047746 Homo sapiens Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 2
- 101001047731 Homo sapiens Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 2
- 101001008558 Homo sapiens Laminin subunit beta-2 Proteins 0.000 description 2
- 101001054646 Homo sapiens Latent-transforming growth factor beta-binding protein 3 Proteins 0.000 description 2
- 101000624625 Homo sapiens M-phase inducer phosphatase 1 Proteins 0.000 description 2
- 101000648395 Homo sapiens Mitochondrial import receptor subunit TOM70 Proteins 0.000 description 2
- 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 2
- 101000957259 Homo sapiens Mitotic spindle assembly checkpoint protein MAD2A Proteins 0.000 description 2
- 101001007909 Homo sapiens Nuclear pore complex protein Nup93 Proteins 0.000 description 2
- 101001124017 Homo sapiens Nuclear transport factor 2 Proteins 0.000 description 2
- 101001098930 Homo sapiens Pachytene checkpoint protein 2 homolog Proteins 0.000 description 2
- 101000730802 Homo sapiens Prefoldin subunit 6 Proteins 0.000 description 2
- 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 2
- 101000817237 Homo sapiens Protein ECT2 Proteins 0.000 description 2
- 101000583797 Homo sapiens Protein MCM10 homolog Proteins 0.000 description 2
- 101000625251 Homo sapiens Protein Mis18-alpha Proteins 0.000 description 2
- 101001074602 Homo sapiens Protein PIMREG Proteins 0.000 description 2
- 101000863978 Homo sapiens Protein downstream neighbor of Son Proteins 0.000 description 2
- 101000831286 Homo sapiens Protein timeless homolog Proteins 0.000 description 2
- 101001087362 Homo sapiens Putative pituitary tumor-transforming gene 3 protein Proteins 0.000 description 2
- 101000579957 Homo sapiens RANBP2-like and GRIP domain-containing protein 8 Proteins 0.000 description 2
- 101000692933 Homo sapiens Ribonuclease 4 Proteins 0.000 description 2
- 101000836005 Homo sapiens S-phase kinase-associated protein 1 Proteins 0.000 description 2
- 101001087372 Homo sapiens Securin Proteins 0.000 description 2
- 101001067604 Homo sapiens Serine hydroxymethyltransferase, mitochondrial Proteins 0.000 description 2
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 2
- 101000713494 Homo sapiens Small nuclear ribonucleoprotein F Proteins 0.000 description 2
- 101000848999 Homo sapiens Tastin Proteins 0.000 description 2
- 101000644684 Homo sapiens Ubiquitin-conjugating enzyme E2 N Proteins 0.000 description 2
- 101000837565 Homo sapiens Ubiquitin-conjugating enzyme E2 S Proteins 0.000 description 2
- 108010063296 Kinesin Proteins 0.000 description 2
- 102000010638 Kinesin Human genes 0.000 description 2
- 102100027631 Kinesin-like protein KIF14 Human genes 0.000 description 2
- 102100023890 Kinetochore protein NDC80 homolog Human genes 0.000 description 2
- 102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 description 2
- 102100027454 Laminin subunit beta-2 Human genes 0.000 description 2
- 102100027020 Latent-transforming growth factor beta-binding protein 3 Human genes 0.000 description 2
- 102100023326 M-phase inducer phosphatase 1 Human genes 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102100028811 Mitochondrial import receptor subunit TOM70 Human genes 0.000 description 2
- 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 2
- 102100038792 Mitotic spindle assembly checkpoint protein MAD2A Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 102100027585 Nuclear pore complex protein Nup93 Human genes 0.000 description 2
- 102100028418 Nuclear transport factor 2 Human genes 0.000 description 2
- 102100038993 Pachytene checkpoint protein 2 homolog Human genes 0.000 description 2
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 2
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 2
- 102100032926 Prefoldin subunit 6 Human genes 0.000 description 2
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 2
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 2
- 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 2
- 102100040437 Protein ECT2 Human genes 0.000 description 2
- 102100030962 Protein MCM10 homolog Human genes 0.000 description 2
- 102100025037 Protein Mis18-alpha Human genes 0.000 description 2
- 102100036258 Protein PIMREG Human genes 0.000 description 2
- 102100029926 Protein downstream neighbor of Son Human genes 0.000 description 2
- 102100024287 Protein timeless homolog Human genes 0.000 description 2
- 102100033003 Putative pituitary tumor-transforming gene 3 protein Human genes 0.000 description 2
- 102100027504 RANBP2-like and GRIP domain-containing protein 8 Human genes 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 102000001218 Rec A Recombinases Human genes 0.000 description 2
- 108010055016 Rec A Recombinases Proteins 0.000 description 2
- 101710146873 Receptor-binding protein Proteins 0.000 description 2
- 102100026411 Ribonuclease 4 Human genes 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 101150063267 STAT5B gene Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 101000620730 Schizosaccharomyces pombe (strain 972 / ATCC 24843) DNA repair protein rhp51 Proteins 0.000 description 2
- 102100033004 Securin Human genes 0.000 description 2
- 102100034606 Serine hydroxymethyltransferase, mitochondrial Human genes 0.000 description 2
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 2
- 102100024474 Signal transducer and activator of transcription 5B Human genes 0.000 description 2
- 102100036758 Small nuclear ribonucleoprotein F Human genes 0.000 description 2
- 102100021919 Syncoilin Human genes 0.000 description 2
- 101710128444 Syncoilin Proteins 0.000 description 2
- 102100034475 Tastin Human genes 0.000 description 2
- 102100036407 Thioredoxin Human genes 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 102100032953 Trophinin Human genes 0.000 description 2
- 101710148378 Trophinin Proteins 0.000 description 2
- 102100028718 Ubiquitin-conjugating enzyme E2 S Human genes 0.000 description 2
- 101710123661 Venom allergen 5 Proteins 0.000 description 2
- 102100040733 Zinc finger protein 395 Human genes 0.000 description 2
- ZPCCSZFPOXBNDL-ZSTSFXQOSA-N [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoe Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ZPCCSZFPOXBNDL-ZSTSFXQOSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000011226 adjuvant chemotherapy Methods 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 108700021031 cdc Genes Proteins 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000004756 chromatid Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000007417 hierarchical cluster analysis Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000008073 immune recognition Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 238000000670 ligand binding assay Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012775 microarray technology Methods 0.000 description 2
- 208000004141 microcephaly Diseases 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 208000010916 pituitary tumor Diseases 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 102100026163 39S ribosomal protein L12, mitochondrial Human genes 0.000 description 1
- 102000012758 APOBEC-1 Deaminase Human genes 0.000 description 1
- 108010079649 APOBEC-1 Deaminase Proteins 0.000 description 1
- 102100022413 ATP-dependent RNA helicase DHX30 Human genes 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 101100455873 Arabidopsis thaliana MKK7 gene Proteins 0.000 description 1
- 101100465060 Arabidopsis thaliana PRK4 gene Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100027515 Baculoviral IAP repeat-containing protein 6 Human genes 0.000 description 1
- 102100027880 Basal body-orientation factor 1 Human genes 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 102100040755 CREB-regulated transcription coactivator 3 Human genes 0.000 description 1
- 101100350185 Caenorhabditis elegans odd-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101150023302 Cdc20 gene Proteins 0.000 description 1
- 102100025053 Cell division control protein 45 homolog Human genes 0.000 description 1
- 102100038099 Cell division cycle protein 20 homolog Human genes 0.000 description 1
- 102100025832 Centromere-associated protein E Human genes 0.000 description 1
- 102100039118 Centromere/kinetochore protein zw10 homolog Human genes 0.000 description 1
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
- 102000052603 Chaperonins Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 102100033682 Cilia- and flagella-associated protein 69 Human genes 0.000 description 1
- 101710126409 Condensin complex subunit 2 Proteins 0.000 description 1
- 102100032952 Condensin complex subunit 3 Human genes 0.000 description 1
- 208000036493 Contralateral breast cancer Diseases 0.000 description 1
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 1
- 101150079793 Crtc3 gene Proteins 0.000 description 1
- 101710157591 Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
- 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 1
- 102100027564 DNA replication complex GINS protein PSF1 Human genes 0.000 description 1
- 102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 101100382570 Danio rerio caspb gene Proteins 0.000 description 1
- 102100036727 Deformed epidermal autoregulatory factor 1 homolog Human genes 0.000 description 1
- 102100029721 DnaJ homolog subfamily B member 1 Human genes 0.000 description 1
- 102100022845 DnaJ homolog subfamily C member 9 Human genes 0.000 description 1
- 102100032246 Double zinc ribbon and ankyrin repeat-containing protein 1 Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000015699 E2F1 Transcription Factor Human genes 0.000 description 1
- 108010063774 E2F1 Transcription Factor Proteins 0.000 description 1
- 102100020865 EKC/KEOPS complex subunit LAGE3 Human genes 0.000 description 1
- 108010003751 Elongin Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 102100030881 Enoyl-CoA hydratase domain-containing protein 2, mitochondrial Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102100024513 F-box only protein 6 Human genes 0.000 description 1
- 108090000652 Flap endonucleases Proteins 0.000 description 1
- 102100035129 Forkhead box protein K2 Human genes 0.000 description 1
- 101710088031 Forkhead box protein K2 Proteins 0.000 description 1
- 102100038722 GPI mannosyltransferase 2 Human genes 0.000 description 1
- 101710102120 GTP-binding protein 4 Proteins 0.000 description 1
- 101150068770 Gcna gene Proteins 0.000 description 1
- 101710110797 Guanylate-binding protein 4 Proteins 0.000 description 1
- 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 1
- 244000139725 Hedeoma drummondii Species 0.000 description 1
- 235000002046 Hedeoma drummondii Nutrition 0.000 description 1
- 102100030673 Histone H2A.V Human genes 0.000 description 1
- 101000691538 Homo sapiens 39S ribosomal protein L12, mitochondrial Proteins 0.000 description 1
- 101000901948 Homo sapiens ATP-dependent RNA helicase DHX30 Proteins 0.000 description 1
- 101000936081 Homo sapiens Baculoviral IAP repeat-containing protein 6 Proteins 0.000 description 1
- 101000697681 Homo sapiens Basal body-orientation factor 1 Proteins 0.000 description 1
- 101000934421 Homo sapiens Cell division control protein 45 homolog Proteins 0.000 description 1
- 101000914247 Homo sapiens Centromere-associated protein E Proteins 0.000 description 1
- 101000743902 Homo sapiens Centromere/kinetochore protein zw10 homolog Proteins 0.000 description 1
- 101000944490 Homo sapiens Cilia- and flagella-associated protein 69 Proteins 0.000 description 1
- 101000942622 Homo sapiens Condensin complex subunit 3 Proteins 0.000 description 1
- 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 1
- 101001080484 Homo sapiens DNA replication complex GINS protein PSF1 Proteins 0.000 description 1
- 101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 1
- 101000929421 Homo sapiens Deformed epidermal autoregulatory factor 1 homolog Proteins 0.000 description 1
- 101000903036 Homo sapiens DnaJ homolog subfamily C member 9 Proteins 0.000 description 1
- 101001016174 Homo sapiens Double zinc ribbon and ankyrin repeat-containing protein 1 Proteins 0.000 description 1
- 101001137983 Homo sapiens EKC/KEOPS complex subunit LAGE3 Proteins 0.000 description 1
- 101000919883 Homo sapiens Enoyl-CoA hydratase domain-containing protein 2, mitochondrial Proteins 0.000 description 1
- 101001052796 Homo sapiens F-box only protein 6 Proteins 0.000 description 1
- 101000907578 Homo sapiens Forkhead box protein M1 Proteins 0.000 description 1
- 101000604574 Homo sapiens GPI mannosyltransferase 2 Proteins 0.000 description 1
- 101001084711 Homo sapiens Histone H2A.V Proteins 0.000 description 1
- 101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
- 101001001331 Homo sapiens Importin subunit alpha-1 Proteins 0.000 description 1
- 101001010724 Homo sapiens Intraflagellar transport protein 88 homolog Proteins 0.000 description 1
- 101001008953 Homo sapiens Kinesin-like protein KIF11 Proteins 0.000 description 1
- 101001027621 Homo sapiens Kinesin-like protein KIF20A Proteins 0.000 description 1
- 101001053809 Homo sapiens Kinetochore-associated protein DSN1 homolog Proteins 0.000 description 1
- 101001003581 Homo sapiens Lamin-B1 Proteins 0.000 description 1
- 101000946306 Homo sapiens Laminin subunit gamma-1 Proteins 0.000 description 1
- 101001054649 Homo sapiens Latent-transforming growth factor beta-binding protein 2 Proteins 0.000 description 1
- 101000800374 Homo sapiens Mitochondrial import inner membrane translocase subunit Tim10 Proteins 0.000 description 1
- 101000794228 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Proteins 0.000 description 1
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
- 101001108356 Homo sapiens Nardilysin Proteins 0.000 description 1
- 101000991410 Homo sapiens Nucleolar and spindle-associated protein 1 Proteins 0.000 description 1
- 101001128742 Homo sapiens Nucleoside diphosphate kinase homolog 5 Proteins 0.000 description 1
- 101000887481 Homo sapiens Probable G-protein coupled receptor 149 Proteins 0.000 description 1
- 101000931680 Homo sapiens Protein furry homolog Proteins 0.000 description 1
- 101000605014 Homo sapiens Putative L-type amino acid transporter 1-like protein MLAS Proteins 0.000 description 1
- 101000582404 Homo sapiens Replication factor C subunit 4 Proteins 0.000 description 1
- 101000580351 Homo sapiens Respirasome Complex Assembly Factor 1 Proteins 0.000 description 1
- 101000927774 Homo sapiens Rho guanine nucleotide exchange factor 12 Proteins 0.000 description 1
- 101000851593 Homo sapiens Separin Proteins 0.000 description 1
- 101000601441 Homo sapiens Serine/threonine-protein kinase Nek2 Proteins 0.000 description 1
- 101000649929 Homo sapiens Serine/threonine-protein kinase VRK1 Proteins 0.000 description 1
- 101000911790 Homo sapiens Sister chromatid cohesion protein DCC1 Proteins 0.000 description 1
- 101000713459 Homo sapiens Small nuclear ribonucleoprotein G Proteins 0.000 description 1
- 101000713169 Homo sapiens Solute carrier family 52, riboflavin transporter, member 2 Proteins 0.000 description 1
- 101000648153 Homo sapiens Stress-induced-phosphoprotein 1 Proteins 0.000 description 1
- 101000666730 Homo sapiens T-complex protein 1 subunit alpha Proteins 0.000 description 1
- 101000866298 Homo sapiens Transcription factor E2F8 Proteins 0.000 description 1
- 101000904868 Homo sapiens Transcriptional regulator ATRX Proteins 0.000 description 1
- 101000653679 Homo sapiens Translationally-controlled tumor protein Proteins 0.000 description 1
- 101000838463 Homo sapiens Tubulin alpha-1A chain Proteins 0.000 description 1
- 101001094573 Homo sapiens U1 small nuclear ribonucleoprotein C Proteins 0.000 description 1
- 101000667300 Homo sapiens WD repeat-containing protein 19 Proteins 0.000 description 1
- 101000743863 Homo sapiens ZW10 interactor Proteins 0.000 description 1
- 101000964713 Homo sapiens Zinc finger protein 395 Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100030007 Intraflagellar transport protein 88 homolog Human genes 0.000 description 1
- 238000010824 Kaplan-Meier survival analysis Methods 0.000 description 1
- 102100027629 Kinesin-like protein KIF11 Human genes 0.000 description 1
- 102100037694 Kinesin-like protein KIF20A Human genes 0.000 description 1
- 102100024062 Kinetochore-associated protein DSN1 homolog Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 102100026517 Lamin-B1 Human genes 0.000 description 1
- 102100038204 Large neutral amino acids transporter small subunit 1 Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000763212 Lype Species 0.000 description 1
- 102100024299 Maternal embryonic leucine zipper kinase Human genes 0.000 description 1
- 101710154611 Maternal embryonic leucine zipper kinase Proteins 0.000 description 1
- 108010079754 Minichromosome Maintenance Complex Component 6 Proteins 0.000 description 1
- 102000012942 Minichromosome Maintenance Complex Component 6 Human genes 0.000 description 1
- 102100033066 Mitochondrial import inner membrane translocase subunit Tim10 Human genes 0.000 description 1
- 102100030144 Mitotic checkpoint serine/threonine-protein kinase BUB1 beta Human genes 0.000 description 1
- 102100023123 Mucin-16 Human genes 0.000 description 1
- ZBZXYUYUUDZCNB-UHFFFAOYSA-N N-cyclohexa-1,3-dien-1-yl-N-phenyl-4-[4-(N-[4-[4-(N-[4-[4-(N-phenylanilino)phenyl]phenyl]anilino)phenyl]phenyl]anilino)phenyl]aniline Chemical compound C1=CCCC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 ZBZXYUYUUDZCNB-UHFFFAOYSA-N 0.000 description 1
- 102100030710 NAD-dependent protein deacetylase sirtuin-3, mitochondrial Human genes 0.000 description 1
- 102100021850 Nardilysin Human genes 0.000 description 1
- 241000375368 Nerine undulata Species 0.000 description 1
- 102100030991 Nucleolar and spindle-associated protein 1 Human genes 0.000 description 1
- 102100032210 Nucleoside diphosphate kinase homolog 5 Human genes 0.000 description 1
- 208000035327 Oestrogen receptor positive breast cancer Diseases 0.000 description 1
- 108010054076 Oncogene Proteins v-myb Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010000598 Polycomb Repressive Complex 1 Proteins 0.000 description 1
- 102100039859 Probable G-protein coupled receptor 149 Human genes 0.000 description 1
- 102100020918 Protein furry homolog Human genes 0.000 description 1
- 102100033947 Protein regulator of cytokinesis 1 Human genes 0.000 description 1
- 102100038206 Putative L-type amino acid transporter 1-like protein MLAS Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000002490 Rad51 Recombinase Human genes 0.000 description 1
- 108010068097 Rad51 Recombinase Proteins 0.000 description 1
- 102000018779 Replication Protein C Human genes 0.000 description 1
- 108010027647 Replication Protein C Proteins 0.000 description 1
- 102100030542 Replication factor C subunit 4 Human genes 0.000 description 1
- 102100027558 Respirasome Complex Assembly Factor 1 Human genes 0.000 description 1
- 102100033193 Rho guanine nucleotide exchange factor 12 Human genes 0.000 description 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
- 108091005770 SIRT3 Proteins 0.000 description 1
- 108091006697 SLC24A1 Proteins 0.000 description 1
- 108091006232 SLC7A5 Proteins 0.000 description 1
- 108091006237 SLC7A6 Proteins 0.000 description 1
- 102000009147 START domains Human genes 0.000 description 1
- 108050000027 START domains Proteins 0.000 description 1
- 101100476033 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) RSR1 gene Proteins 0.000 description 1
- 101100010298 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pol2 gene Proteins 0.000 description 1
- 102100036750 Separin Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100037703 Serine/threonine-protein kinase Nek2 Human genes 0.000 description 1
- 102100028235 Serine/threonine-protein kinase VRK1 Human genes 0.000 description 1
- 244000191761 Sida cordifolia Species 0.000 description 1
- 108050002485 Sirtuin Proteins 0.000 description 1
- 102000011990 Sirtuin Human genes 0.000 description 1
- 102100027040 Sister chromatid cohesion protein DCC1 Human genes 0.000 description 1
- 102100036768 Small nuclear ribonucleoprotein G Human genes 0.000 description 1
- 102000016177 Sodium/potassium/calcium exchanger Human genes 0.000 description 1
- 108050004685 Sodium/potassium/calcium exchanger Proteins 0.000 description 1
- 102100036947 Sodium/potassium/calcium exchanger 1 Human genes 0.000 description 1
- 102100036862 Solute carrier family 52, riboflavin transporter, member 2 Human genes 0.000 description 1
- 102100030992 Sorting nexin-1 Human genes 0.000 description 1
- 101710103909 Sorting nexin-1 Proteins 0.000 description 1
- 108050003387 Stathmin Proteins 0.000 description 1
- 102000005465 Stathmin Human genes 0.000 description 1
- 102100025292 Stress-induced-phosphoprotein 1 Human genes 0.000 description 1
- 102100026185 Syncollin Human genes 0.000 description 1
- 101710168213 Syncollin Proteins 0.000 description 1
- 102100038410 T-complex protein 1 subunit alpha Human genes 0.000 description 1
- 102000001639 Thioredoxin Reductase 1 Human genes 0.000 description 1
- 108010093836 Thioredoxin Reductase 1 Proteins 0.000 description 1
- 102100031555 Transcription factor E2F8 Human genes 0.000 description 1
- 102100023931 Transcriptional regulator ATRX Human genes 0.000 description 1
- 102100029887 Translationally-controlled tumor protein Human genes 0.000 description 1
- 102100028968 Tubulin alpha-1A chain Human genes 0.000 description 1
- 102100035136 U1 small nuclear ribonucleoprotein C Human genes 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 101710192923 Ubiquitin-conjugating enzyme E2 N Proteins 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 102100039744 WD repeat-containing protein 19 Human genes 0.000 description 1
- 102100032803 Y+L amino acid transporter 2 Human genes 0.000 description 1
- 102100039102 ZW10 interactor Human genes 0.000 description 1
- 101710146675 Zinc finger protein 395 Proteins 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 102000005352 centromere protein F Human genes 0.000 description 1
- 108010031377 centromere protein F Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 201000007281 estrogen-receptor positive breast cancer Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000004547 gene signature Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 108010052263 lamin B1 Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 208000026535 luminal A breast carcinoma Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000017156 mRNA modification Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- GPLGAQQQNWMVMM-FCGWIEHOSA-N nerine Chemical compound C1C=C2CC(N(C)C)CC[C@]2(C)C2C1C1CCC3C(C)N(C)C[C@@]31CC2 GPLGAQQQNWMVMM-FCGWIEHOSA-N 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- RJIWZDNTCBHXAL-UHFFFAOYSA-N nitroxoline Chemical compound C1=CN=C2C(O)=CC=C([N+]([O-])=O)C2=C1 RJIWZDNTCBHXAL-UHFFFAOYSA-N 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 230000030147 nuclear export Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 230000004650 oncogenic pathway Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 108010005636 polypeptide C Proteins 0.000 description 1
- 238000011240 pooled analysis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004557 prognostic gene signature Effects 0.000 description 1
- 102000034272 protein filaments Human genes 0.000 description 1
- 108091005974 protein filaments Proteins 0.000 description 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000005051 syncoilin Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- VGZTVHRJEVWFIA-UHFFFAOYSA-N synthane Chemical compound FC(F)OC(F)C(F)(F)C(F)F VGZTVHRJEVWFIA-UHFFFAOYSA-N 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 102000004217 thyroid hormone receptors Human genes 0.000 description 1
- 108090000721 thyroid hormone receptors Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000005029 transcription elongation Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 108010005491 trypsin carboxypeptidase peptide inhibitor Proteins 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Theoretical Computer Science (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68054305P | 2005-05-13 | 2005-05-13 | |
| US60/680,543 | 2005-05-13 | ||
| EP05447274 | 2005-12-07 | ||
| EP05447274.1 | 2005-12-07 | ||
| PCT/BE2006/000051 WO2006119593A1 (en) | 2005-05-13 | 2006-05-15 | Gene-based algorithmic cancer prognosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2608643A1 true CA2608643A1 (en) | 2006-11-16 |
Family
ID=36061623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002608643A Abandoned CA2608643A1 (en) | 2005-05-13 | 2006-05-15 | Gene-based algorithmic cancer prognosis |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1880335A1 (zh) |
| JP (1) | JP2008539737A (zh) |
| CN (1) | CN101356532B (zh) |
| AU (1) | AU2006246241A1 (zh) |
| CA (1) | CA2608643A1 (zh) |
| WO (1) | WO2006119593A1 (zh) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| US9856533B2 (en) | 2003-09-19 | 2018-01-02 | Biotheranostics, Inc. | Predicting breast cancer treatment outcome |
| US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
| US20080286273A1 (en) * | 2007-05-02 | 2008-11-20 | Siemens Medical Solutions Usa, Inc. | Knowledge-Based Proliferation Signatures and Methods of Use |
| US7960114B2 (en) | 2007-05-02 | 2011-06-14 | Siemens Medical Solutions Usa, Inc. | Gene signature of early hypoxia to predict patient survival |
| CN102395682B (zh) * | 2007-09-06 | 2015-09-30 | 生物治疗诊断股份有限公司 | 肿瘤分级和癌症预后 |
| AU2008294687A1 (en) | 2007-09-07 | 2009-03-12 | Universite Libre De Bruxelles | Methods and tools for prognosis of cancer in ER- patients |
| CA2695814A1 (en) * | 2007-09-07 | 2009-04-23 | Universite Libre De Bruxelles | Methods and tools for prognosis of cancer in her2+ patients |
| WO2009103790A2 (en) | 2008-02-21 | 2009-08-27 | Universite Libre De Bruxelles | Method and kit for the detection of genes associated with pik3ca mutation and involved in pi3k/akt pathway activation in the er-positive and her2-positive subtypes with clinical implications |
| JPWO2009113495A1 (ja) * | 2008-03-12 | 2011-07-21 | 財団法人ヒューマンサイエンス振興財団 | 肝癌特異的発現遺伝子による肝癌の検査方法並びに肝癌の治療及び予防剤 |
| ES2595410T3 (es) * | 2009-01-07 | 2016-12-29 | Myriad Genetics, Inc. | Biomarcadores de cáncer |
| US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| CA2782620A1 (en) * | 2009-12-01 | 2011-06-09 | Compendia Bioscience, Inc. | Classification of cancers |
| BR112012019640A2 (pt) * | 2010-02-05 | 2017-06-20 | Translational Genomics Res Inst | métodos e kits usados na classificação de carcinoma adrenocortical |
| KR101864855B1 (ko) * | 2010-03-31 | 2018-07-13 | 지피돈 디아그노스틱스 게엠베하 | 내분비 치료 중 유방암 재발 예측 방법 |
| EP2591126B1 (en) | 2010-07-07 | 2020-12-30 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
| EP2648762B1 (en) | 2010-12-09 | 2018-02-21 | Biotheranostics, Inc. | Post-treatment breast cancer prognosis |
| US20140228241A1 (en) | 2011-07-28 | 2014-08-14 | Sividon Diagnostics Gmbh | Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrentbreast cancer |
| JP2013219629A (ja) | 2012-04-10 | 2013-10-24 | Sony Computer Entertainment Inc | 情報処理装置および録画機器選択方法 |
| US10408846B2 (en) * | 2012-05-15 | 2019-09-10 | Novartis Ag | Quantitative methods and kits for providing reproducible IHC4 scores |
| EP4190918A1 (en) | 2012-11-16 | 2023-06-07 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| WO2014118333A1 (en) | 2013-02-01 | 2014-08-07 | Sividon Diagnostics Gmbh | Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer |
| CN103205433B (zh) * | 2013-04-03 | 2014-06-04 | 复旦大学附属肿瘤医院 | 用于肺癌预后的基因及其应用 |
| KR101636995B1 (ko) * | 2014-02-05 | 2016-07-21 | 연세대학교 산학협력단 | 도메인 특이적인 계통발생학적 프로파일 유사성을 이용한 유전자 네트워크의 개선 방법 |
| CA2947624A1 (en) | 2014-05-13 | 2015-11-19 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| DK3303618T3 (da) * | 2015-05-29 | 2019-12-16 | Koninklijke Philips Nv | Fremgangsmåder til prognose af prostatacancer |
| CN106442991B (zh) * | 2015-08-06 | 2018-07-27 | 中国人民解放军军事医学科学院生物医学分析中心 | 用于预测肺腺癌患者预后及判断辅助化疗获益的系统 |
| MX2018005867A (es) | 2015-11-13 | 2018-09-21 | Biotheranostics Inc | Integracion de las caracteristicas tumorales con el indice de cancer de mama. |
| WO2017189976A1 (en) | 2016-04-29 | 2017-11-02 | Board Of Regents, The University Of Texas System | Targeted measure of transcriptional activity related to hormone receptors |
| CN107326065B (zh) * | 2016-04-29 | 2022-07-29 | 博尔诚（北京）科技有限公司 | 一种基因标识物的筛选方法及其应用 |
| WO2019051266A2 (en) | 2017-09-08 | 2019-03-14 | Myriad Genetics, Inc. | METHOD OF USING BIOMARKERS AND CLINICAL VARIABLES TO PREDICT THE INTEREST OF CHEMOTHERAPY |
| CN108648826B (zh) * | 2018-05-09 | 2022-04-15 | 中国科学院昆明动物研究所 | 一种基于多基因表达特征谱的胰腺癌个性化预后评估方法 |
| CN108424970B (zh) * | 2018-06-13 | 2021-04-13 | 深圳市颐康生物科技有限公司 | 用于检测癌症复发风险的生物标志物及检测方法 |
| CN112760384B (zh) * | 2021-04-06 | 2021-06-25 | 臻和(北京)生物科技有限公司 | 一种胰腺癌预后判定方法及装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030198972A1 (en) * | 2001-12-21 | 2003-10-23 | Erlander Mark G. | Grading of breast cancer |
| GB0323225D0 (en) * | 2003-10-03 | 2003-11-05 | Ncc Technology Ventures Pte Lt | Materials and methods relating to breast cancer classification |
-
2006
- 2006-05-15 WO PCT/BE2006/000051 patent/WO2006119593A1/en not_active Application Discontinuation
- 2006-05-15 AU AU2006246241A patent/AU2006246241A1/en not_active Abandoned
- 2006-05-15 CA CA002608643A patent/CA2608643A1/en not_active Abandoned
- 2006-05-15 JP JP2008510367A patent/JP2008539737A/ja active Pending
- 2006-05-15 EP EP06752698A patent/EP1880335A1/en not_active Ceased
- 2006-05-15 CN CN2006800164096A patent/CN101356532B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006246241A1 (en) | 2006-11-16 |
| JP2008539737A (ja) | 2008-11-20 |
| EP1880335A1 (en) | 2008-01-23 |
| CN101356532B (zh) | 2012-08-01 |
| CN101356532A (zh) | 2009-01-28 |
| WO2006119593A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2608643A1 (en) | Gene-based algorithmic cancer prognosis | |
| US20120071346A1 (en) | Gene-based algorithmic cancer prognosis | |
| Bertucci et al. | Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy | |
| EP2333112B1 (en) | Breast cancer prognostics | |
| JP2007049991A (ja) | 乳癌の骨への再発の予測 | |
| US20190085407A1 (en) | Methods and compositions for diagnosis of glioblastoma or a subtype thereof | |
| JP2020500515A (ja) | 乳がん患者の予後の予測方法 | |
| US8030060B2 (en) | Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer | |
| KR20140105836A (ko) | 다유전자 바이오마커의 확인 | |
| US20070059706A1 (en) | Materials and methods relating to breast cancer classification | |
| CN109072481B (zh) | 早期乳腺癌内分泌治疗后剩余风险的基因特征 | |
| EP2558599A1 (en) | Methods of evaluating response to cancer therapy | |
| US20140154681A1 (en) | Methods to Predict Breast Cancer Outcome | |
| EP3964589A1 (en) | Assessing colorectal cancer molecular subtype and uses thereof | |
| Stec et al. | Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips | |
| EP2406729B1 (en) | A method, system and computer program product for the systematic evaluation of the prognostic properties of gene pairs for medical conditions. | |
| US9195796B2 (en) | Malignancy-risk signature from histologically normal breast tissue | |
| Reinholz et al. | Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform | |
| Rathnagiriswaran et al. | A population-based gene signature is predictive of breast cancer survival and chemoresponse | |
| US10240206B2 (en) | Biomarkers and methods for predicting benefit of adjuvant chemotherapy | |
| Duffy et al. | DNA microarray-based gene expression profiling in cancer: aiding cancer diagnosis, assessing prognosis and predicting response to therapy | |
| EP2872651B1 (en) | Gene expression profiling using 5 genes to predict prognosis in breast cancer | |
| JP5963748B2 (ja) | 中枢神経原発悪性リンパ腫患者の予後予測方法、キット及び使用 | |
| Pusztai et al. | Personalizing Treatment Selection for Breast Cancer | |
| WO2021061623A1 (en) | Methods for predicting aml outcome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20140210 |